ÂÜÀòÂÒÂ×

Julie Storms is a Senior Scientist at 272BIO Limited since August 2022, contributing to protein drug development through innovative chromatographic and mass spectrometric methodologies. Prior to this role, Julie served as Team Lead and Scientist-Project Manager in the Biologics team at RIC group, where responsibility included the development of protein drug candidates. Julie's career at Ablynx spanned from October 2008 to March 2017, holding positions including Associate Scientist and Senior Research Associate, focusing on the analysis, stability, and quality control of Nanobodies® during all stages of development. Julie's foundational education includes an Industrieel Ingenieur degree in Biochemie from HOWEST Hogeschool West-Vlaanderen and studies at Ghent University.